16th Jun 2022

NICE to evaluate the Genedrive® MT-RNR1 Test under their Diagnostics Assessment Programme

genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that the UK...

30th May 2022

Point-of-Care Genedrive® COV19-ID Kit receives Coronavirus Test Device Approval (“CTDA”)

genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that the UK...

29th Mar 2022

Interim results to 31 December 2021

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces unaudited i...